PharmiWeb.com - Global Pharma News & Resources
25-Oct-2023

Gilead Sciences ranked by Newsweek as a one of the UK’s ‘Most Loved Workplaces of 2023’

Gilead Sciences ranked by Newsweek as a one of the UK’s ‘Most Loved Workplaces of 2023’

Newsweek has recognised Gilead Sciences for its “outstanding employee sentiment and satisfaction” as part of its annual list of Most Loved Workplaces.

25th October, London:

Gilead Sciences has been named as one of the UK’s Most Loved Workplaces of 2023 and recognised for its “outstanding employee sentiment and satisfaction”, as part of Newsweek’s annual survey of more than 2 million employees.

Newsweek’s 2023 Top 100 Most Loved Workplaces® is the result of a collaboration with the Best Practice Institute (BPI), a leadership development and benchmark research company. It recognises 100 companies that have created workplaces where employees feel respected, inspired, and appreciated and are at the centre of the business model. This includes data on employee sentiment, how positive they feel about their workplace, how committed they are to their organisation’s success, and how valued they feel as individuals.

In the findings, Gilead was highlighted as a socially responsible and ethical company, with a culture of inclusion and supporting teams with health, wellness, and development resources.  Commenting on the news, Dr Véronique Walsh, General Manager & VP, UK & Ireland, Gilead Sciences said:

“I am delighted we have been recognised as one of the UK’s Most Loved Workplaces of 2023. At Gilead, we firmly believe people are our greatest asset.  Our dedicated team of scientists, clinicians, and experts across multiple fields are united by the passion and commitment to make a difference to the patients and communities we serve. 

This recognition from Newsweek is testament to our employees’ contributions in realising this vision and fostering an environment of inclusivity and innovation for patients.  I would like to thank all my Gilead colleagues for making it happen.”

Editor Details

Last Updated: 25-Oct-2023